GRAIL

Proactive #cancer screening can change the course of patient care. Dr. Daniel Mackey at Mercy and Dr. Tyler Kang at Adventist Health discuss the impact of multi-cancer early detection (MCED) testing on early diagnosis and treatment: https://bit.ly/4eBJfEO

Today, we honor the life and legacy of Dr. Martin Luther King Jr., whose unwavering commitment to justice, equality, and inclusion continues to inspire us. His vision challenges us to reflect on how far we’ve come and motivates us to keep building a brighter future—for our workplaces, communities, and beyond. At GRAIL, we believe that fostering a culture of diversity, equity, inclusion, and belonging strengthens us all. By embracing different perspectives, we spark innovation, deepen connection, and create an environment where everyone feels valued and empowered. Let’s honor Dr. King’s courage and commitment by continuing to foster spaces where everyone can thrive. #MLKDay #DiversityAndInclusion #Belonging

When Cindy received her cancer signal detected result, she was shocked; she felt fine and had no symptoms. But thanks to follow-up diagnostic testing, her cancer was caught early. Watch Cindy’s full story to see how she’s doing today: https://lnkd.in/gFMeN2c3

In a recent PATHFINDER study published in Lancet Oncology, an analysis of patient-reported outcomes showed minimal patient distress associated with multi-cancer early detection (MCED) testing. Eligible PATHFINDER study participants, with either a cancer signal detected or no cancer signal detected over a 12-month follow-up period, were assessed on their perspectives of general anxiety, distress and uncertainty after results disclosure, health-related quality of life, satisfaction with the test, and intent towards guideline-recommended screening and repeat MCED testing. Learn more: https://bit.ly/4gSlmui

Neil thought his #cancer was in the past, but he received a Cancer Signal Detected result from a multi-cancer early detection test. Neil explains how early cancer screening made a difference in his cancer journey.

Cancer survivors often face a higher risk of new cancers due to the impact of prior cancer treatments, in addition to several other factors. On #TheCancerSignal, Dr. Eric Klein shares insights from the PATHFINDER study and other GRAIL data from 2024, revealing how multi-cancer early detection (MCED) testing can help survivors screen for recurrence and new cancers earlier. Hear about these important findings on proactive cancer screening. Apple Podcasts: https://apple.co/49vtDBR Spotify: https://spoti.fi/4io6YLz Transcripts and more: https://bit.ly/3Lx4g6t

Reflecting on the potential impact of multi-cancer early detection (MCED) testing, Dr. Daniel Mackey says, “If we can diagnose our patients at an earlier stage, not only does it improve their quality of life, and improve the morbidity associated with the treatments, but we can also reduce health care costs.” Hear from Dr. Mackey and Dr. Tyler Kang with Adventis Health about their experiences using MCED testing for cancer screening in this video.

Dak Prescott is on a mission to help people detect cancer early and through his foundation - Faith Fight, Finish - he is doing just that. Thank you Tad Carper of the Dallas Cowboys for sharing this impactful story of multi-cancer early detection. Rx only. See Important Safety Information: https://lnkd.in/d_fp9JR5 The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

In 2024, health systems across the U.S. continued to make significant strides toward expanding early cancer detection screening. In fact, more than 11,000 health care providers have ordered the Galleri test to date. Hear from leading physicians on how the adoption of multi-cancer early detection (MCED) screening is helping address an urgent unmet need. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests. Rx only. See Important Safety Information: http://bit.ly/33m8pFa #MCED #EarlyDetection #CancerScreening

We’re wrapping up 2024 with a research update with Dr. Eric Klein, Distinguished Scientist at GRAIL. In this episode of #TheCancerSignal, Dr. Klein shares GRAIL’s highlights from ASCO, ESMO, AACR and more - findings on repeat multi-cancer early detection (MCED) testing, MCED use in cancer survivors, economic impacts of cancer screening, and even a couple case studies. Don’t miss this episode! Apple Podcasts: https://apple.co/49vtDBR Spotify: https://spoti.fi/4io6YLz Transcripts and more: https://bit.ly/3Lx4g6t